Home＞ORGANIZATION
NPO Asks MHLW to Take Steps to Ensure Proper Use of Xeplion(Jun.23.2016)
The nonprofit organization Community Mental Health & Welfare Bonding Organization (COMHBO) submitted a request to the Ministry of Health, Labor and Welfare (MHLW) on June 21 regarding the proper use of the antipsychotic agent Xeplion Aqueous Suspension for IM Injection ...
(LOG IN FOR FULL STORY)
-
- Generic Use Rate at 74.1% in January-March: JGA Jul.04
- Yokokura Wins 4th Term to Lead Japan Medical Association Jun.25
- Expand Exemption Criteria in New Off-Patent Price Cut Rule: Japan Pharma Lobby Jun.19
- Japan Pharma Group Calls for Careful Approach on PMP Deduction for Comparator Drugs Jun.19
- Don’t Make Coverage Decision on CEA, Tweak Prices with Limited Scope: FPMAJ Jun.18
- J-TEC Submits Trial Protocol for Autologous Cultured Cartilage in Knee Osteoarthritis Use(Jul.20)
- Toray, Bonac to Begin US PI Trial of Nucleic Acid for IPF(Jul.20)
- Subcutaneous Vedolizumab Hits Primary Endpoint in PIII: Takeda(Jul.20)
- Takeda, Ovid Launching 3 New Studies for Rare Epilepsy Drug(Jul.20)
- Steep Hikes in Prices of Chinese-Made APIs Could Hit Generic Makers Hard(Jul.20)
